Retatrutide 20mg + Tirzepatide 40mg
$239.00Choose a specification to see its price.
Description
Product Overview
- Full Name: Combined GLP-1/GIP/GCGR Triple Agonist Blend
- Core Mechanism
- Dual synergistic activation of GLP-1, GIP and glucagon receptors to suppress appetite sharply.
- Slow gastric emptying, reduce calorie intake and improve insulin sensitivity.
- Boost lipolysis, lower visceral fat and regulate long-term blood glucose levels.
- Control hunger hormones to avoid rebound overeating after cycle completion.
- Purity: ≥ 99% (Endotoxin < 1 EU/mg)
Product Attributes
| Attribute | Details |
|---|---|
| Purity | ≥ 99% full batch inspection, endotoxin level below 1 EU/mg |
| Unreconstituted Storage | -20 ± 5°C, sealed, protected from light and moisture, 24-month shelf life |
| Post-Reconstitution Storage | Refrigerate at 2–8°C, finish all liquid within 28 days; freezing is prohibited |
| Appearance | White to off-white lyophilized powder blend |
| Administration Route | Subcutaneous injection only |
Product documentation
Specifications have not been published.
Batch reports
No public batches have been published for this product.
Additional information
| Specifications | 60mg*10 vials |
|---|
Related products
-
AOD9604
Current price: $36.000 published batchesView details -
LL37
Current price: $88.000 published batchesView details -
Retatrutide
Current price: $86.30Regular price: $102.0015% off0 published batchesView details -
CJC-1295 no DAC
Current price: $30.000 published batchesView details
Reviews
There are no reviews yet.